Diagnostic applications of microarrays

被引:42
作者
Petrik, J. [1 ]
机构
[1] Univ Edinburgh, Scottish Natl Blood TRansfus Serv, TTI, RVDS Summerhall, Edinburgh EH9 1QH, Midlothian, Scotland
[2] Univ Edinburgh, Dept Med Microbiol, Edinburgh, Midlothian, Scotland
关键词
biochip; blood screening; blood testing; cancer; infectious disease; in vitro diagnostics; microarray; nucleic acid testing; point-of-care; typing;
D O I
10.1111/j.1365-3148.2006.00673.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microarrays were designed to monitor the expression of many genes in parallel, providing substantially more information than Northern blots or reverse transcription polymerase chain reaction analysing one or few genes at a time. The large sequencing projects provided the content for detailed expression studies under a variety of stimuli and conditions. The human genome project identified around 30 000 human genes. Estimated number of protein products is, however, 10-30 times higher, mainly due to the alternative splicing and post-translational modifications. The identification of gene functions requires both genomic and proteomic approaches, including protein microarrays, and numerous current microarray projects focus on deciphering gene expression patterns under a variety of conditions. Establishing the key genes and gene products for particular conditions opens the way for diagnostic applications using multiparameter, high-throughput assays. This format can also accommodate existing blood screening assays, potentially providing a single testing platform. This review considers the progress in diagnostic microarrays in a wider context of in vitro diagnostics field.
引用
收藏
页码:233 / 247
页数:15
相关论文
共 101 条
  • [51] Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients
    Kohlmann, A
    Schoch, C
    Schnittger, S
    Dugas, M
    Hiddemann, W
    Kern, W
    Haferlach, T
    [J]. LEUKEMIA, 2004, 18 (01) : 63 - 71
  • [52] Tissue microarrays for high-throughput molecular profiling of tumor specimens
    Kononen, J
    Bubendorf, L
    Kallioniemi, A
    Bärlund, M
    Schraml, P
    Leighton, S
    Torhorst, J
    Mihatsch, MJ
    Sauter, G
    Kallioniemi, OP
    [J]. NATURE MEDICINE, 1998, 4 (07) : 844 - 847
  • [53] Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis
    Kozak, KR
    Amneus, MW
    Pusey, SM
    Su, F
    Luong, MN
    Luong, SA
    Reddy, ST
    Farias-Eisner, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) : 12343 - 12348
  • [54] Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays
    Kuruvilla, FG
    Shamji, AF
    Sternson, SM
    Hergenrother, PJ
    Schreiber, SL
    [J]. NATURE, 2002, 416 (6881) : 653 - 657
  • [55] Stem cell-ness: a "magic marker" for cancer
    Lahad, JP
    Mills, GB
    Coombes, KR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (06) : 1463 - 1467
  • [56] Genetics of hypertension: from experimental models to clinical applications
    Lee, WK
    Padmanabhan, S
    Dominiczak, AF
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (10-11) : 631 - 647
  • [57] Salivary transcriptome diagnostics for oral cancer detection
    Li, Y
    St John, MAR
    Zhou, XF
    Kim, Y
    Sinha, U
    Jordan, RCK
    Eisele, D
    Abemayor, E
    Elashoff, D
    Park, NH
    Wong, DT
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8442 - 8450
  • [58] Use of oligonucleotide microarrays for rapid detection and serotyping of acute respiratory disease-associated adenoviruses
    Lin, BC
    Vora, GJ
    Thach, D
    Walter, E
    Metzgar, D
    Tibbetts, C
    Stenger, DA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) : 3232 - 3239
  • [59] LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442
  • [60] LITTLE S, 2005, IVD TECHNOLOGY NOV, P33